478 related articles for article (PubMed ID: 14564225)
1. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
Fonarow GC; Horwich TB
Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
[TBL] [Abstract][Full Text] [Related]
2. Cardiac troponin levels in heart failure.
Potluri S; Ventura HO; Mulumudi M; Mehra MR
Cardiol Rev; 2004; 12(1):21-5. PubMed ID: 14667259
[TBL] [Abstract][Full Text] [Related]
3. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.
Horwich TB; Patel J; MacLellan WR; Fonarow GC
Circulation; 2003 Aug; 108(7):833-8. PubMed ID: 12912820
[TBL] [Abstract][Full Text] [Related]
4. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
5. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
[TBL] [Abstract][Full Text] [Related]
6. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of N-terminal proB-type natriuretic peptide.
Costello-Boerrigter LC; Burnett JC
Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
[TBL] [Abstract][Full Text] [Related]
8. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality.
Provenchère S; Berroeta C; Reynaud C; Baron G; Poirier I; Desmonts JM; Iung B; Dehoux M; Philip I; Bénessiano J
Crit Care Med; 2006 Apr; 34(4):995-1000. PubMed ID: 16484891
[TBL] [Abstract][Full Text] [Related]
9. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
Omland T
Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
[TBL] [Abstract][Full Text] [Related]
10. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
Oral I; Mistrík J; Náplava R
Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
[TBL] [Abstract][Full Text] [Related]
11. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
12. [Brain natriuretic peptide].
Tsutamoto T; Horie M
Rinsho Byori; 2004 Aug; 52(8):655-68. PubMed ID: 15478621
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
14. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
15. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
16. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
Fonarow GC; Peacock WF; Horwich TB; Phillips CO; Givertz MM; Lopatin M; Wynne J;
Am J Cardiol; 2008 Jan; 101(2):231-7. PubMed ID: 18178412
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
Wiviott SD; de Lemos JA; Morrow DA
Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
[TBL] [Abstract][Full Text] [Related]
19. BNP in the diagnosis and risk stratification of heart failure.
Moe GW
Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
[TBL] [Abstract][Full Text] [Related]
20. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]